Correlation Engine 2.0
Clear Search sequence regions

  • anterior chamber (1)
  • cases (5)
  • cataract (5)
  • city (2)
  • drug combinations (2)
  • drug costs (1)
  • female (1)
  • humans (1)
  • internship (1)
  • patients (3)
  • pupil (9)
  • solutions (2)
  • tamsulosin (3)
  • Sizes of these terms reflect their relevance to your search.

    To compare the use of topical dilation drops vs topical drops with the addition of intracameral epinephrine in resident-performed cataract surgery and the effects on pupil expansion device (PED) use, surgical costs, and surgical times. Iowa City Veterans Affairs Medical Center, Iowa City, Iowa, USA. Retrospective chart review. Resident-performed primary cataract surgical cases using topical dilation drops only or drops with the addition of intracameral epinephrine were analyzed for PED use, surgical time, and costs in all patients and in patients with a history of tamsulosin use. In the topical group, PEDs were used in 31.1% of cases compared with 13.5% of cases in the intracameral group (P < .0001). History of tamsulosin use was noted in about one third of cases in both groups. For patients with a history of tamsulosin use, PED use decreased from 52.7% in the topical cases to 17.9% in the intracameral group (P < .0001). Surgical times were on average 7.1 minutes slower with PED use than without PED use. There was a medication savings of $50.44 USD per case in the intracameral group compared with the topical group. Factoring in the $100 to $130 USD per PED used, total surgical costs were $19‚ÄČ267 USD less in the intracameral group over 6 months. Intracameral epinephrine with lidocaine decreases the need for PED use during cataract surgery, lowers intraoperative costs, and improves efficiency compared with topical dilation drops alone.


    Caroline W Wilson, Lauren E Hock, Thomas Oetting, Sean Kennedy, Daniel Terveen. Pupil expansion device use and operative outcomes with topical dilation vs intracameral epinephrine in resident-performed cataract surgery. Journal of cataract and refractive surgery. 2020 Apr;46(4):562-566

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32271295

    View Full Text